Fig. 3From: Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three yearsThe number of women who entered and continued in the short term (< 3 years) and longer term (≥3 years) oral bisphosphonate (BP) treatment groups during ten years of follow-upBack to article page